Arnulf Ferlitsch

Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis

Mattias Mandorfer, Simona Bota, Philipp Schwabl et al. · Gastroenterology · 2014 · 369 citations

Hepatology, Liver Physiology, Hepatorenal Syndrome +10

Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol

Thomas Reiberger, Gregor Ulbrich, Arnulf Ferlitsch et al. · Gut · 2012 · 329 citations · Full text

Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis

Thomas Reiberger, Arnulf Ferlitsch, B.A. Payer et al. · Journal of Hepatology · 2012 · 318 citations

Inflammation, Intestinal Permeability, Non-selective Betablocker Therapy +11

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

Mattias Mandorfer, K Kozbial, Philipp Schwabl et al. · Journal of Hepatology · 2016 · 298 citations

Hepatology, Viral Hepatitis, Immunology +8

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease

Mònica Pons, Salvador Augustín, Bernhard Scheiner et al. · The American Journal of Gastroenterology · 2020 · 223 citations